The contribution of chronic kidney disease to the global burden of major noncommunicable diseases
KT Woo, HL Choong, KS Wong, HB Tan… - Kidney …, 2012 - kidney-international.org
1044 Kidney International (2012) 81, 1043–1045 letter to the editor but the incidence of
ESRF due to DiabNx has not stabilized. 3 There is also the growing concern that long-term
use of ACEIs/ARBs could promote renal fibrosis. 4 This may be one explanation of why the
incidence of ESRF due to DiabNx has not plateaued despite the stabilization of the
incidence of ESRF. Perhaps the time has come for ISN experts to focus on the burden of
ESRF due to DiabNx in these countries.
ESRF due to DiabNx has not stabilized. 3 There is also the growing concern that long-term
use of ACEIs/ARBs could promote renal fibrosis. 4 This may be one explanation of why the
incidence of ESRF due to DiabNx has not plateaued despite the stabilization of the
incidence of ESRF. Perhaps the time has come for ISN experts to focus on the burden of
ESRF due to DiabNx in these countries.